Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.
Mirshafiey
Abbas
A
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. mirshafiey@tums.ac.ir
Jadidi-Niaragh
Farhad
F
D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D018077:Receptors, Leukotriene / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism
D020024:Leukotriene Antagonists; D016859:Lipoxygenase Inhibitors; D018077:Receptors, Leukotriene; D001094:Arachidonate 5-Lipoxygenase